Log in to save to my catalogue

Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk...

Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2707618016

Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies

About this item

Full title

Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies

Publisher

England: BMJ Publishing Group Ltd and European League Against Rheumatism

Journal title

Annals of the rheumatic diseases, 2023-02, Vol.82 (2), p.246-252

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd and European League Against Rheumatism

More information

Scope and Contents

Contents

ObjectivesIn dermatomyositis (DM), autoantibodies are associated with unique clinical phenotypes. For example, anti-TIF1γ autoantibodies are associated with an increased risk of cancer. The purpose of this study was to discover novel DM autoantibodies.MethodsPhage ImmunoPrecipitation Sequencing using sera from 43 patients with DM suggested that tra...

Alternative Titles

Full title

Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2707618016

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2707618016

Other Identifiers

ISSN

0003-4967,1468-2060

E-ISSN

1468-2060

DOI

10.1136/ard-2022-222441

How to access this item